Merck | MRK - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Adidas EUR 1.16B 286M 2026-06
Adyen EUR 12.25B 1.82B 2026-06
Akzo Nobel EUR 2.76B 1.14B 2026-03
Alcon AG USD 1.58B 80M 2026-03
Amadeus IT EUR 677.2M 298.4M 2026-03
Amarin USD 143.56M 12.5M 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
BASF EUR 7.8B 4.71B 2026-06
Bayer EUR 4.29B 1.44B 2026-06
Beiersdorf EUR 1.2B 33M 2025-12
Covestro EUR 648M 44M 2025-12
Danone EUR 1.98B 364M 2025-12
Fresenius EUR 2.06B 752M 2026-03
Fresenius Medical Care EUR 1.06B 177.89M 2026-06
Genmab DKK 1.5B 18M 2026-06
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 513M 189M 2026-06
Henkel EUR 2.71B 163M 2025-12
Hikma Pharmaceutical USD 217M 19M 2025-12
Infineon EUR 1.07B 232M 2026-06
Lakefront Biotherapeutics EUR 135.95M 69.15M 2026-06
Linde USD 3.96B 1.1B 2026-03
Lonza CHF 719M 188M 2025-12
Merck EUR 2.74B 415M 2026-03
Novartis USD 7.62B 739M 2026-06
Philips EUR 1.79B 803M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
UCB EUR 1.57B 1.14B 2024-12